Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.

[1]  E. Antman,et al.  ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .

[2]  P. Lapuerta,et al.  A health perception score predicts cardiac events in patients with heart failure: results from the IMPRESS trial. , 2001, Journal of cardiac failure.

[3]  R. Califf,et al.  Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure. , 2000, American heart journal.

[4]  I. Piña,et al.  Tolerability of extended duration intravenous milrinone in patients hospitalized for advanced heart failure and the usefulness of uptitration of oral angiotensin-converting enzyme inhibitors. , 1999, The American journal of cardiology.

[5]  J. Croft,et al.  Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. , 1999, American heart journal.

[6]  R. Quigg,et al.  Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure. , 1998, The American journal of cardiology.

[7]  B. Massie,et al.  Optimizing therapy for complex or refractory heart failure: a management algorithm. , 1998, American heart journal.

[8]  R. Bonow,et al.  Chronic heart failure in the United States: a manifestation of coronary artery disease. , 1998, Circulation.

[9]  J. Feinglass,et al.  Heart failure between 1986 and 1994: temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical center. , 1997, American heart journal.

[10]  R. Bonow,et al.  Pharmacotherapy for systolic dysfunction: a review of randomized clinical trials. , 1997, The American journal of cardiology.

[11]  J. Feinglass,et al.  Systolic function, readmission rates, and survival among consecutively hospitalized patients with congestive heart failure. , 1997, American heart journal.

[12]  L. Goldman,et al.  Correlates of major complications or death in patients admitted to the hospital with congestive heart failure. , 1996, Archives of internal medicine.

[13]  M. Hess,et al.  Milrinone: basic and clinical pharmacology and acute and chronic management. , 1996, The American journal of the medical sciences.

[14]  M. Bristow,et al.  Economic impact of heart failure in the United States: time for a different approach. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  D. Levy,et al.  The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.

[16]  M D Hughes,et al.  Reporting Bayesian analyses of clinical trials. , 1993, Statistics in medicine.

[17]  J. Cohn,et al.  Effect of Enalapril, Hydralazine Plus Isosorbide Dinitrate, and Prazosin on Hospitalization in Patients With Chronic Congestive Heart Failure , 1993, Circulation.

[18]  P E Leaverton,et al.  Prevalence and mortality rate of congestive heart failure in the United States. , 1992, Journal of the American College of Cardiology.

[19]  D. DeMets,et al.  Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.

[20]  M. Rich,et al.  Early Readmission of Elderly Patients With Congestive Heart Failure , 1990, Journal of the American Geriatrics Society.

[21]  R. Cooper,et al.  Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence. , 1990, Archives of internal medicine.

[22]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[23]  R. A. Johnson,et al.  Heart failure in outpatients: a randomized trial of digoxin versus placebo. , 1982, The New England journal of medicine.